Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Tracon Pharmaceuticals, Inc. (TCON)
Sector: Healthcare; Industry: Biotechnology

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-01-27 THEUER CHARLES President and CEO Buy 11,000 $8.98 $98,771 No
2020-10-21 THEUER CHARLES President and CEO Buy 2,000 $4.38 $8,769 No
2020-09-23 THEUER CHARLES President and CEO Buy 5,000 $4.72 $23,599 No
2020-09-04 THEUER CHARLES President and CEO Buy 10,000 $2.58 $25,750 No
2020-08-21 THEUER CHARLES President and CEO Buy 5,325 $1.56 $8,307 No
2020-08-20 THEUER CHARLES President and CEO Buy 30,000 $1.58 $47,400 No
2020-08-18 THEUER CHARLES President and CEO Buy 44,843 $1.63 $73,021 No
2020-08-13 THEUER CHARLES President and CEO Buy 20,000 $1.73 $34,500 No
2020-06-24 THEUER CHARLES President and CEO Buy 9,895 $1.90 $18,800 No
2020-05-22 THEUER CHARLES President and CEO Buy 10,592 $1.90 $20,119 No
2020-03-13 THEUER CHARLES President and CEO Buy 4,100 $1.13 $4,624 No
2020-03-12 THEUER CHARLES President and CEO Buy 20,000 $1.43 $28,639 No
2020-03-10 THEUER CHARLES President and CEO Buy 10,000 $1.87 $18,691 No
2019-08-09 THEUER CHARLES President and CEO Buy 50,000 $0.45 $22,500 No
2018-12-21 THEUER CHARLES President and CEO Buy 49,000 $0.66 $32,222 No
2015-09-18 THEUER CHARLES President and CEO Sell 10,000 $17.34 $173,400 Yes
2015-09-10 THEUER CHARLES President and CEO Sell 3,516 $12.00 $42,192 No
2015-08-14 THEUER CHARLES President and CEO Sell 100 $12.00 $1,200 No

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.